Position in NVO
as of Mar 31, 2026
· filed Apr 7, 2026
Position Value
$14,171,535
+$4,313,434 QoQ
Shares Held
385,620
+99.0% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.51%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2021
19 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026U.S. Capital Wealth Advisors, LLC holds $125,986,971 across 13 Drug Manufacturers - General names. NVO ranks #4 (11.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
157,263 | $38,441,367 | |
| 2 | MRK |
Merck & Co., Inc.
|
137,497 | $16,539,514 | |
| 3 | LLY |
ELI LILLY & Co
|
17,474 | $16,072,060 | |
| 4 | NVO |
Novo Nordisk A S
This page
|
385,620 | $14,171,535 | |
| 5 | PFE |
Pfizer Inc
|
500,221 | $14,046,205 | |
| 6 | ABBV |
AbbVie Inc.
|
52,656 | $11,452,153 | |
| 7 | AMGN |
Amgen Inc
|
20,942 | $7,368,442 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
39,903 | $2,420,116 |
All Filings in NVO
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $14,171,535 | 385,620 | Shares | Sole | 2026-04-07 | |
| 2025-12-31 | $9,858,101 | 193,752 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $5,143,645 | 92,695 | Shares | Sole | 2025-10-09 | |
| 2025-06-30 | $3,312,131 | 47,988 | Shares | Sole | 2025-07-14 | |
| 2025-03-31 | $609,197 | 8,773 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $596,118 | 6,930 | Shares | Sole | 2025-01-24 | |
| 2024-09-30 | $834,085 | 7,005 | Shares | Sole | 2024-10-22 | |
| 2024-06-30 | $2,601,008 | 18,222 | Shares | Sole | 2024-07-11 | |
| 2024-03-31 | $2,734,021 | 21,293 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $1,595,302 | 15,421 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $1,394,201 | 15,331 | Shares | Sole | 2023-10-19 | |
| 2023-06-30 | $1,355,649 | 8,377 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $1,379,107 | 8,666 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $1,200,059 | 8,867 | Shares | Sole | 2023-02-03 | |
| 2022-09-30 | $808,796 | 8,118 | Shares | Sole | 2022-11-01 | |
| 2022-06-30 | $896,454 | 8,045 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $853,974 | 7,690 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $869,344 | 7,762 | Shares | Sole | 2022-01-21 | |
| 2021-09-30 | $702,121 | 7,313 | Shares | Sole | 2021-11-01 | |
| No filing history on record for this holder in this stock. | ||||||